These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2530623)

  • 21. [Diagnostic and therapeutic problems in hypertensive heart disease].
    Strauer BE
    Z Kardiol; 1993; 82 Suppl 4():17-24. PubMed ID: 8147058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kidney and hypertension].
    Menne J; Fliser D; Haller H
    Herz; 2006 Jun; 31(4):317-21. PubMed ID: 16810471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why?
    Paul B; Goyal RK
    Indian Heart J; 2000; 52(1):19-22. PubMed ID: 10820928
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy for juvenile hypertension].
    Matsushita K; Umemura S
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):227-33. PubMed ID: 12652726
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The heart and essential hypertension].
    Amodeo C; Frohlich ED
    Arq Bras Cardiol; 1985 Jan; 44(1):53-5. PubMed ID: 2933013
    [No Abstract]   [Full Text] [Related]  

  • 28. Left ventricular hypertrophy in hypertension and the effects of antihypertensive drug therapy.
    Hachamovitch R; Sonnenblick EH; Strom JA; Frishman WH
    Curr Probl Cardiol; 1988 Jun; 13(6):375-421. PubMed ID: 2978689
    [No Abstract]   [Full Text] [Related]  

  • 29. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic regression of cardiac hypertrophy in experimental hypertension.
    Pfeffer MA; Pfeffer JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S865-9. PubMed ID: 6084141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic progress in the area of arterial hypertension].
    Verniory A; Demanet JC
    Brux Med; 1974 Oct; 54(10):551-8. PubMed ID: 4373143
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy.
    Leenen FH; Tsoporis J
    Eur Heart J; 1990 Nov; 11 Suppl G():100-6. PubMed ID: 2150031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac fibrosis triggered by the kidney: a case report.
    Saeed A; Guron G; Oldfors A; Lindelöw B; Herlitz H
    Nephrol Dial Transplant; 2006 Jun; 21(6):1713-5. PubMed ID: 16554331
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
    Sheiban I; Arosio E; Tonni S; Montresor G; Priante F; Lechi A
    Eur Heart J; 1992 Jun; 13 Suppl A():37-44. PubMed ID: 1356775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.